Follow-The-Filings

Security · featured owners

RPRX Royalty Pharma PLC

Health Care SHS CLASS A Equity as of 2026 Q2 among managers we track

  • 4 Owners
  • Max 8.8%
  • $393M
  • 2 add 2 reduce 1 exit

RPRX (Royalty Pharma PLC) is held in 4 featured 13F books as of 2026 Q2. Pat Dorsey - Dorsey Asset Management is the largest tracked holder by portfolio weight (8.8%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 8.8% (Pat Dorsey - Dorsey Asset Management) · not free-float ownership

  1. Pat Dorsey add 8.8%
  2. Samantha Mclemore reduce 6.6%
  3. Torray Investment Partners reduce 4.6%
  4. Murray Stahl add 0.22%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Samantha Mclemore - Patient Capital Management 2026 Q2 6.6% Reduce −1.2% 3,598,808 $202M history
Pat Dorsey - Dorsey Asset Management 2026 Q2 8.8% Add +7.9% 2,456,528 $138M history
Torray Investment Partners 2026 Q2 4.6% Reduce −6.7% 602,028 $34M history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 0.22% Add +1.2% 344,861 $19M history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0.13% Exit −0.13% 493,000 $24M history

4 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01 Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 rows shown

Filed Form Detail Links
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 13, 2026 Filing Doc
4 Period Aug 5, 2026 · 4 forms Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Jun 23, 2026 Filing Doc
4 Period Jun 24, 2026 Filing Doc
4 Period Jun 5, 2026 · 8 forms Filing Doc
4 Period May 26, 2026 Filing Doc
4 Period May 20, 2026 Filing Doc
4 Period May 14, 2026 · 2 forms Filing Doc
4 Period May 6, 2026 · 2 forms Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.35B $2.26B $2.38B
Net income $1.13B $0.859B $0.771B
Net margin * 48.2% 37.9% 32.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.27B $1.8B $1.53B
Total non-current assets * $15.11B $16.42B $18.09B
Total assets $16.38B $18.22B $19.62B
Total current liabilities $0.161B $1.25B $0.636B
Total non-current liabilities * $6.14B $6.63B $9.27B
Total equity $10.08B $10.34B $9.71B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $2.99B $2.77B $2.49B
Cash from investing -$2.07B -$2.68B -$1.61B
Cash from financing -$2.15B $0.361B -$1.19B
Net change in cash -$1.23B $0.452B -$0.31B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders